Illumina news from FierceBioResearcher
NewsSequencing outfits sign up for $60M genome project
Three top DNA sequencing companies - 454 Life Sciences, Illumina and Applied Biosystems -- have joined forces with the 1000 Genomes project, putting their technology to work mapping the human genome Read more...
Illumina offers understanding of molecular mechanisms
San Diego-based Illumina is commercializing three new products aimed at a better understanding of the molecular mechanisms that give rise to cancer. Illumina's DASL Assay is designed to profile Read more...
| Press ReleasesIllumina Creates Two New Business Units Illumina Creates Two New Business Units SAN DIEGO -- Illumina today announced that it has reorganized its operating structure to further leverage the synergies between its sequencing and genotyping Read more... |
Get more Illumina coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets